TGFB1 and neoplasm: Thus, as a tumor promoter, TGF‐β stimulates both Smad and non‐Smad signaling (termed tumor promoter signaling), leading to epithelial mesenchymal transition (EMT), autoinduction, invasiveness, and chemoresistance in these cancer cells.